Expired Canadian patentCanada
Compositions of melanoma differentiation associated gene-7 (mda-7) in cancer diagnosis and treatment
CA 2174354 C · Owner: Jiang, Hongping · Inventors: Fisher, Paul B.; Jiang, Hongping
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to an isolated mda-7 nucleic acid encoding the MDA-7 amino acid sequence of SEQ ID NO:7, the use of the mda-7 gene in the preparation of a pharmaceutical composition and a method of detecting the expression of said gene.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 1994 and granted March 29, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 24, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 24, 1994
GrantedMarch 29, 2011
Term endedOctober 24, 2014
Patent numberCA 2174354 C
Classification (IPC)C12N15/19 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.